A large-scale genome-wide association study published in Nature in April 2026, conducted by 23andMe researchers using data from 27,885 GLP-1 medication users, identified a specific variant in the GLP1R gene the gene that encodes the primary receptor these drugs target associated with differential weight loss efficacy
Whether youre managing side effects or considering surgery, our expert team is here to guide your next step
sAXagliptin (Monograph) Drug class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Introduction Antidiabetic agent
Always seek the advice of a qualified healthcare provider with any questions about a medical condition
In Singapore, Tirzepatide was approved in 2023 by Health Sciences Authority (HSA) for the treatment of type 2 diabetes
You can discover a full spectrum of premium solutions for your daily care by visiting this aesthetic beauty page, where every choice leads toward healthy and radiant skin